This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Journal of Pharmaceutical Innovation Open Access 26 November 2021
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
McKinsey. Biosimilars seven years on: where are we and what’s next? https://www.mckinsey.com/~/media/mckinsey/dotcom/client_service/Pharma%20and%20Medical%20Products/PMP%20NEW/PDFs/Biosimilars%20Seven%20years%20on_White%20Paper.ashx (2013).
Gross, H. J. & Vietri, F. Barriers to Biologic Therapy Use for Autoimmune Disorders in Emerging Markets, International Society for Pharmacoeconomics and Outcomes Research: 16th Annual European Conference (2013).
Ghosh, A., Ray, S., Dewan, S., Shah, K. & Sahani, K. Indian Pharmaceutical Sector (ICRA Ltd., New Delhi, 2012).
Pharmaceutical Export Promotion Council of India. 11th Annual Report, 2014–2015 (Government of India, Bangalore, India, 2015).
Edney, A. & Mittelman, M. Valeant, Turing would face subpoena vote under Democrat’s plan. Bloomberg http://www.bloomberg.com/news/articles/2015-11-04/valeant-turing-would-face-subpoena-vote-under-democrats-plan (4 November 2015).
Kateja, N., Agarwal, H., Hebbi, V. & Rathore, A. S. Biotechnol. Prog. 33, 998–1009 (2017).
The authors declare no competing interests.
About this article
Cite this article
Rathore, A.S., Shereef, F. The influence of domestic manufacturing capabilities on biologic pricing in emerging economies. Nat Biotechnol 37, 498–501 (2019). https://doi.org/10.1038/s41587-019-0116-0
This article is cited by
Nature Biotechnology (2022)
Journal of Pharmaceutical Innovation (2022)
Nature Biotechnology (2021)